Skip to main content
. 2021 Aug 12;2(3):100740. doi: 10.1016/j.xpro.2021.100740

Table 2.

LC-MS/MS conditions and parameters for program 1

Name MRM Dwell (s) CV (V) CE (V) Mode Retention time (min) Time window ± (min) Performance
Norvaline 117.9 → 54.9 0.005 24 16 ESI+ 7.2 0.2 ∗∗
Tryptophan (Trp) 205.1 → 118.0 0.005 22 26 ESI+ 7.4 0.2 ∗∗
Tyrosine (Tyr) 182.0 → 136.1 0.005 20 12 ESI+ 8.0 0.15 ∗∗
Arginine (Arg) 175.1 → 70.0 0.005 34 20 ESI+ 10.6 0.4 ∗∗∗
Phenylalanine (Phe) 166.0 → 120.1 0.005 24 12 ESI+ 7.1 0.3 ∗∗
Histidine (His) 156.0 → 110.0 0.005 26 14 ESI+ 10.7 0.5 ∗∗∗
Methionine (Met) 150.0 → 56.0 0.005 22 16 ESI+ 7.6 0.2 ∗∗
Glutamic acid (Glu) 148.0 → 84.0 0.005 20 16 ESI+ 8.8 0.35 ∗∗∗
Lysine (Lys) 147.0 → 67.0 0.005 22 26 ESI+ 10.8 0.3 ∗∗∗
Glutamine (Gln) 147.0 → 41.0 0.005 22 24 ESI+ 9.3 0.35 ∗∗
Aspartic acid (Asp) 134.0 → 73.9 0.005 20 12 ESI+ 9.1 0.4
Asparagine (Asn) 133.0 → 73.9 0.005 20 14 ESI+ 9.4 0.35 ∗∗∗
Isoleucine (Ile) 132.0 → 69.0 0.005 20 16 ESI+ 7.3 0.25 ∗∗
Leucine (Leu) 132.0 → 43.4 0.005 20 22 ESI+ 7.0 0.2 ∗∗
Cysteine (Cys) 122.0 → 75.9 0.005 18 12 ESI+ 8.2 0.35
Threonine (Thr) 120.0 → 56.0 0.005 48 14 ESI+ 8.7 0.35 ∗∗∗
Valine (Val) 118.0 → 72.0 0.005 20 10 ESI+ 7.7 0.3 ∗∗
Proline (Pro) 116.0 → 70.0 0.005 30 12 ESI+ 7.8 0.4 ∗∗
Serine (Ser) 106.0 → 60.0 0.005 22 8 ESI+ 9.2 0.4 ∗∗∗
Alanine (Ala) 90.0 → 44.0 0.005 20 8 ESI+ 8.4 0.2 ∗∗
Glycine (Gly) 75.9 → 29.8 0.005 18 6 ESI+ 8.8 0.3 ∗∗∗
Glutathione (GSH) 308 → 179 0.005 20 10 ESI+ 8.4 0.2 ∗∗∗
Glutathione disulfide (GSSG) 613 → 355 0.005 40 20 ESI+ 11.5 0.1 ∗∗∗
Ascorbic acid 175 → 115 0.005 40 10 ESI- 4.4 0.25
S-Adenosyl-L-methionine (SAM) 399 → 250 0.005 20 10 ESI+ 11.3 0.2 ∗∗
S-Adenosyl-L-homocysteine (SAH) 385 → 136 0.005 20 20 ESI+ 9.8 0.1 ∗∗
Myo-inositol 179.2 → 86.9 0.005 40 12 ESI- 9.1 0.1 ∗∗

Note: Italicized metabolites are referenced from a database (https://metlin.scripps.edu) but not confirmed with standards. CV: cone voltage; CE: collision energy; Performance is evaluated based on how easily peak identification could be done with 10 μL injected hESC sample that was extracted as described in Method 1. ∗∗∗, single peak, easily identified; ∗∗, multiple peaks, target peak could be identified based on the retention time of the standard or by comparing the isotopic ratio, and target peak is not overlapped with other peaks; ∗, multiple peaks, very weak (below 3 folds of baseline) target peak intensity and/or target peak overlaps with other peaks.